Patents by Inventor Detlef Hasse

Detlef Hasse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
    Publication number: 20060159707
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic FlgE peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms.
    Type: Application
    Filed: March 21, 2006
    Publication date: July 20, 2006
    Inventors: Michael Panaccio, Everett Rosey, Meri Sinistaj, Detlef Hasse, Jim Parsons, Robert Ankenbauer
  • derived gene and related OmpH polypeptides, peptides and proteins and their uses
    Patent number: 7052697
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic OmpH peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: May 30, 2006
    Assignees: Agriculture Victoria Services PTY LTD, Pig Research and Development Corp.
    Inventors: Detlef Hasse, Michael Panaccio, Meri Sinistaj
  • derived gene and related hemolysin polypeptides, peptides and proteins and their uses
    Patent number: 7029683
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic hemolysin peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: April 18, 2006
    Assignees: Pfizer Products, Inc., Agriculture Victoria Services Pty. Ltd., Pig Research and Development Corporation
    Inventors: Michael Panaccio, Everett Lee Rosey, Detlef Hasse, Robert Gerard Ankenbauer
  • Therapeutic and diagnostic compositions
    Patent number: 7022328
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. The present invention also contemplates methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganism.
    Type: Grant
    Filed: November 29, 1996
    Date of Patent: April 4, 2006
    Assignee: Australian Pork Limited
    Inventors: Michael Panaccio, Detlef Hasse
  • Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
    Publication number: 20060018920
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic OmpH peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms.
    Type: Application
    Filed: August 30, 2005
    Publication date: January 26, 2006
    Inventors: Detlef Hasse, Michael Panaccio, Meri Sinistaj
  • Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
    Publication number: 20030157120
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic FlgE peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms.
    Type: Application
    Filed: August 13, 2002
    Publication date: August 21, 2003
    Inventors: Michael Panaccio, Everett Lee Rosey, Meri Sinistaj, Detlef Hasse, Jim Parsons, Robert Gerard Ankenbauer